MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 3.190
+0.070 (2.24%)
Aug 21, 2026, 5:35 PM CET
MaaT Pharma Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -31.06 | -28.9 | -19.72 | -13.71 | -9.02 |
Depreciation & Amortization | 1.74 | 1.55 | 0.79 | 0.37 | 0.29 |
Other Amortization | - | 0.14 | 0.08 | 0.06 | 0.04 |
Stock-Based Compensation | 1.67 | 1.53 | 0.87 | 0.65 | 0.79 |
Other Operating Activities | 1.05 | 0.27 | -0.31 | 0.08 | 0.19 |
Change in Accounts Receivable | -0.05 | -0.95 | 0.35 | -0.32 | -0.39 |
Change in Inventory | -0.02 | 0.13 | -0.14 | -0.01 | -0.03 |
Change in Accounts Payable | 2.99 | 2.48 | 1.84 | 2.04 | 1.07 |
Change in Other Net Operating Assets | 7.98 | 1.73 | -2.43 | -1.75 | -0.86 |
Operating Cash Flow | -15.72 | -22.04 | -18.67 | -12.61 | -7.93 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.61 | -0.75 | -1.09 | -0.66 | -0.24 |
Sale of Property, Plant & Equipment | 0 | - | - | - | - |
Investment in Securities | 0.11 | -0.06 | 0.01 | -0.2 | - |
Other Investing Activities | 0.23 | 0.4 | 0.64 | 0.05 | - |
Investing Cash Flow | -0.27 | -0.42 | -0.44 | -0.82 | -0.24 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 3.24 | 5.12 | - | 7.48 | 0.46 |
Long-Term Debt Repaid | -2.89 | -3.58 | -4.19 | -1.93 | -0.95 |
Net Debt Issued (Repaid) | 0.35 | 1.54 | -4.19 | 5.55 | -0.49 |
Issuance of Common Stock | 20.81 | 17.26 | 12.59 | 0.1 | 32.44 |
Repurchase of Common Stock | -0.05 | - | -0.08 | -0.14 | - |
Other Financing Activities | -0.42 | -0.47 | -0.18 | -0.15 | -0.1 |
Financing Cash Flow | 20.7 | 18.33 | 8.14 | 5.36 | 31.56 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Miscellaneous Cash Flow Adjustments | -0 | - | 0 | -0 | - |
Net Cash Flow | 4.71 | -4.13 | -10.97 | -8.06 | 23.39 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -16.33 | -22.79 | -19.76 | -13.27 | -8.17 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -360.88% | -708.77% | -887.03% | -927.76% | -840.23% |
Free Cash Flow Per Share | -1.02 | -1.75 | -1.74 | -1.34 | -3.37 |
Levered Free Cash Flow | -14.16 | -12.25 | -11.13 | -8.04 | -4.99 |
Unlevered Free Cash Flow | -13.37 | -11.71 | -10.88 | -7.92 | -4.92 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.42 | 0.49 | 0.18 | 0.15 | 0.1 |
Change in Working Capital | 10.89 | 3.38 | -0.38 | -0.05 | -0.21 |